David Dodwell

15.3k total citations · 3 hit papers
188 papers, 5.5k citations indexed

About

David Dodwell is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, David Dodwell has authored 188 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Oncology, 104 papers in Cancer Research and 44 papers in Pathology and Forensic Medicine. Recurrent topics in David Dodwell's work include Breast Cancer Treatment Studies (92 papers), Global Cancer Incidence and Screening (42 papers) and Breast Lesions and Carcinomas (40 papers). David Dodwell is often cited by papers focused on Breast Cancer Treatment Studies (92 papers), Global Cancer Incidence and Screening (42 papers) and Breast Lesions and Carcinomas (40 papers). David Dodwell collaborates with scholars based in United Kingdom, United States and Australia. David Dodwell's co-authors include Paul McGale, Kieran Horgan, Sarah C. Darby, Robert E. Coleman, David Cameron, Anthony Howell, Carolyn Taylor, Frances Duane, Andrew Wardley and Julie Povall and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Dodwell

176 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

2017 536 citations Frances Duane, David Dodwell et al. Journal of Clinical Oncology profile →
Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

2005 505 citations David Dodwell et al. Journal of Clinical Oncology profile →
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality

2022 175 citations Amanda Kerr, David Dodwell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Dodwell United Kingdom	39	2.9k	1.9k	1.1k	1.1k	710	188	5.5k
Peter Barrett‐Lee United Kingdom	35	2.6k 0.9×	1.4k 0.7×	671 0.6×	828 0.8×	586 0.8×	121	5.0k
Constance Cirrincione United States	38	6.8k 2.4×	4.7k 2.5×	1.6k 1.4×	1.1k 1.0×	810 1.1×	81	9.8k
L. Campion France	42	1.9k 0.6×	1.4k 0.8×	1.2k 1.1×	1.1k 1.0×	229 0.3×	185	6.2k
S. Ashley United Kingdom	47	3.1k 1.1×	2.0k 1.1×	2.1k 1.8×	1.1k 1.0×	1.2k 1.7×	127	7.1k
M. Spielmann France	47	4.6k 1.6×	3.1k 1.6×	1.8k 1.6×	583 0.5×	455 0.6×	181	7.2k
James J. Dignam United States	40	3.2k 1.1×	3.9k 2.1×	1.5k 1.3×	644 0.6×	1.3k 1.8×	97	7.4k
Jean-Marc Ferrero France	41	6.4k 2.2×	3.0k 1.6×	4.0k 3.5×	2.0k 1.9×	561 0.8×	207	9.6k
Michael L. Cher United States	42	2.0k 0.7×	1.6k 0.9×	2.5k 2.2×	437 0.4×	381 0.5×	165	5.5k
S. Ashley United Kingdom	39	2.6k 0.9×	1.3k 0.7×	1.5k 1.3×	674 0.6×	1.3k 1.8×	80	6.1k
Oreste Gentilini Italy	38	2.7k 0.9×	3.4k 1.8×	625 0.5×	356 0.3×	604 0.9×	151	5.8k

Countries citing papers authored by David Dodwell

Since Specialization

Citations

This map shows the geographic impact of David Dodwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dodwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dodwell more than expected).

Fields of papers citing papers by David Dodwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dodwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dodwell. The network helps show where David Dodwell may publish in the future.

Co-authorship network of co-authors of David Dodwell

This figure shows the co-authorship network connecting the top 25 collaborators of David Dodwell. A scholar is included among the top collaborators of David Dodwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dodwell. David Dodwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stobart, Hilary, et al.. (2025). Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: a systematic review. npj Breast Cancer. 11(1). 32–32. 1 indexed citations

Nicum, Shibani, Kenneth K. C. Man, David Dodwell, et al.. (2025). Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study. PubMed. 8. 100143–100143.

Nicum, Shibani, Kenneth K. C. Man, David Dodwell, et al.. (2025). Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in England. European Journal of Cancer. 222. 115472–115472.

Kaidar‐Person, Orit, Philip Poortmans, Birgitte Vrou Offersen, et al.. (2025). Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of view. European Journal of Surgical Oncology. 51(10). 110310–110310.

Miller, Katie, Melissa Gannon, Francisco J. Medina, et al.. (2024). Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort study. BJS Open. 8(4). 1 indexed citations

Holt, Francesca, Zhe Wang, Sarah C. Darby, et al.. (2024). Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015–2023. Clinical Oncology. 36(9). e322–e332. 4 indexed citations

Gathani, Toral, Ramsey Cutress, David Dodwell, et al.. (2023). Age and sex can predict cancer risk in people referred with breast symptoms. BMJ. 381. e073269–e073269. 6 indexed citations

McIntosh, Stuart, Charlotte E. Coles, David Dodwell, et al.. (2023). SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer—A UK phase III randomised multi-centre trial.. Journal of Clinical Oncology. 41(16_suppl). TPS625–TPS625. 2 indexed citations

Clift, Ash Kieran, David Dodwell, Simon Lord, et al.. (2023). Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ. 381. e073800–e073800. 46 indexed citations

10.

Dodwell, David, John Broggio, Jackie Charman, et al.. (2023). Ki67 and breast cancer mortality in women with invasive breast cancer. JNCI Cancer Spectrum. 7(5). 3 indexed citations

11.

Clift, Ashley Kieran, Julia Hippisley–Cox, David Dodwell, et al.. (2022). Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study. BMJ Open. 12(3). e050828–e050828. 8 indexed citations

12.

Maxwell, Anthony, Bridget Hilton, Karen Clements, et al.. (2022). Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. The Breast. 61. 145–155. 21 indexed citations

13.

Bundred, James, Sarah Michael, Beth Stuart, et al.. (2022). Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis. BMJ. 378. e070346–e070346. 61 indexed citations

14.

Clements, Karen, David Dodwell, Bridget Hilton, et al.. (2022). Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia. BMJ Open. 12(12). e061585–e061585. 3 indexed citations

15.

Clift, Ash Kieran, David Dodwell, Simon Lord, et al.. (2021). The current status of risk-stratified breast screening. British Journal of Cancer. 126(4). 533–550. 67 indexed citations

16.

Gannon, Melissa, David Dodwell, Kieran Horgan, et al.. (2020). Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England. Journal of Geriatric Oncology. 11(5). 836–842. 8 indexed citations

17.

Maxwell, Anthony, Karen Clements, Bridget Hilton, et al.. (2018). Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. European Journal of Surgical Oncology. 44(4). 429–435. 66 indexed citations

18.

Mannu, Gurdeep & David Dodwell. (2017). Making progress in early breast cancer: Taking time or accepting risk?. European Journal of Cancer. 78. 24–27. 2 indexed citations

19.

Dodwell, David, H. Thorpe, & Robert E. Coleman. (2009). Refining systemic therapy for early breast cancer: difficulties with subtraction. The Lancet Oncology. 10(8). 738–739. 4 indexed citations

20.

Wardley, Andrew, N. Davidson, Peter Barrett‐Lee, et al.. (2005). Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. British Journal of Cancer. 92(10). 1869–1876. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact